Cargando…
Rapamycin up-regulates triglycerides in hepatocytes by down-regulating Prox1
BACKGROUND: Although the prolonged use of rapamycin may cause unwanted side effects such as hyperlipidemia, the underlying mechanism remains unknown. Prox1 is a transcription factor responsible for the development of several tissues including lymphatics and liver. There is growing evidences that Pro...
Autores principales: | Kwon, Sora, Jeon, Ji-Sook, Kim, Su Bin, Hong, Young-Kwon, Ahn, Curie, Sung, Jung-Suk, Choi, Inho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769820/ https://www.ncbi.nlm.nih.gov/pubmed/26922671 http://dx.doi.org/10.1186/s12944-016-0211-x |
Ejemplares similares
-
PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells
por: Kwon, Sora, et al.
Publicado: (2022) -
Opposing Regulation of PROX1 by Interleukin-3 Receptor and NOTCH Directs Differential Host Cell Fate Reprogramming by Kaposi Sarcoma Herpes Virus
por: Yoo, Jaehyuk, et al.
Publicado: (2012) -
Up-regulation of fibrinogen-like protein 2 in porcine endothelial cells by xenogeneic CD40 signal
por: Cho, Bumrae, et al.
Publicado: (2018) -
PROX1 is a transcriptional regulator of MMP14
por: Gramolelli, Silvia, et al.
Publicado: (2018) -
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics
por: Bui, Khoa, et al.
Publicado: (2020)